A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer (Prospect)
Clinical Trial ID NCT01322490
PubWeight™ 63.19‹?›
🔗 Visit the ClinicalTrials.gov page for NCT01322490
Top papers
Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
Next 100